Dermocort 1,372 mg/g Aerozol na skórę, zawiesina Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

dermocort 1,372 mg/g aerozol na skórę, zawiesina

tarchomińskie zakłady farmaceutyczne "polfa" s.a. - hydrocortisonum - aerozol na skórę, zawiesina - 1,372 mg/g

Cabometyx Unia Europejska - polski - EMA (European Medicines Agency)

cabometyx

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - Środki przeciwnowotworowe - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.